MICROFLUOROMETRIC EVALUATION OF CALCEIN ACETOXYMETHYL ESTER AS A PROBE FOR P-GLYCOPROTEIN-MEDIATED RESISTANCE - EFFECTS OF CYCLOSPORINE-A AND ITS NONIMMUNOSUPPRESSIVE ANALOG SDZ-PSC-833

被引:56
作者
LIMINGA, G
NYGREN, P
LARSSON, R
机构
[1] UNIV UPPSALA HOSP,DIV CLIN PHARMACOL,S-75185 UPPSALA,SWEDEN
[2] UNIV UPPSALA HOSP,DEPT ONCOL,S-75185 UPPSALA,SWEDEN
关键词
D O I
10.1006/excr.1994.1146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A microtiter plate-based fluorometric assay for functional measurement of 170-kDa P-glycoprotein (Pgp)-mediated transport using fluorescent calcein as a probe is described. The myeloma RPMI 8226 cell line and two of its doxorubicin-resistant Pgp-expressing sublines, dox40 (high expression) and dox6 (low expression), were used as models. Nonfluorescent calcein acetoxymethyl ester (calcein/AM) was added to the cells and subsequent accumulation of calcein was measured in a 96-well scanning fluorometer after 30 min. There was an inverse relationship between Pgp expression and calcein/AM accumulation, which increased dose-dependently in the presence of cyclosporin A (CsA) and the nonimmunosuppressive analogue SDZ PSC 833 (PSC) in the Pgp-expressing cell lines. PSC appeared to restore uptake more effectively than CsA at low concentrations. Calcein accumulation was also increased in Pgp-expressing cells by the addition of the Pgp substrate vincristine and the metabolic inhibitor potassium cyanide, KCN. No effect was observed in parental cell lines. When parental and dox40 cells were mixed, 10% of dox40 cells could reproducibly be detected. The results indicate that microtiter-plate determination of calcein accumulation is a simple and sensitive method for functional determination of Pgp-mediated drug transport. The method may become useful, not only for preclinical screening for novel and improved resistance modifiers, but also for determination of Pgp activity in individual clinical tumor samples. (C) 1994 Academic Press, Inc.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 24 条
[1]   THE CELL BIOLOGY OF MULTIPLE-DRUG RESISTANCE [J].
BECK, WT .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (18) :2879-2887
[2]  
DALTON WS, 1989, BLOOD, V73, P747
[3]  
FORD JM, 1990, PHARMACOL REV, V42, P156
[4]  
GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163
[5]  
HABER DA, 1992, BLOOD, V79, P295
[6]   EXPRESSION OF MDR1 AND MDR3 MULTIDRUG-RESISTANCE GENES IN HUMAN ACUTE AND CHRONIC LEUKEMIAS AND ASSOCIATION WITH STIMULATION OF DRUG ACCUMULATION BY CYCLOSPORINE [J].
HERWEIJER, H ;
SONNEVELD, P ;
BAAS, F ;
NOOTER, K .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1133-1140
[7]   SDZ PSC-833 - A NOVEL POTENT INVITRO CHEMOSENSITIZER IN MULTIPLE-MYELOMA [J].
JONSSON, B ;
NILSSON, K ;
NYGREN, P ;
LARSSON, R .
ANTI-CANCER DRUGS, 1992, 3 (06) :641-646
[8]   PHARMACOLOGICAL MODIFICATION OF MULTIDRUG RESISTANCE (MDR) INVITRO DETECTED BY A NOVEL FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY - REVERSAL OF RESISTANCE AND SELECTIVE CYTOTOXIC ACTIONS OF CYCLOSPORINE-A AND VERAPAMIL ON MDR LEUKEMIA T-CELLS [J].
LARSSON, R ;
NYGREN, P .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (01) :67-72
[9]  
LING V, 1992, CANCER-AM CANCER SOC, V69, P2603, DOI 10.1002/1097-0142(19920515)69:10<2603::AID-CNCR2820691034>3.0.CO
[10]  
2-E